Pure Global

REACTIVO PARA DETERMINACIÓN CUANTITATIVA DE CA15-3 (ANTÍGENO CANCERÍGENO 15-3) - COFEPRIS Registration 1247R2024 SSA

Access comprehensive regulatory information for REACTIVO PARA DETERMINACIÓN CUANTITATIVA DE CA15-3 (ANTÍGENO CANCERÍGENO 15-3) (REACTIVO PARA DETERMINACIÓN CUANTITATIVA DE CA15-3 (ANTÍGENO CANCERÍGENO 15-3)) in the Mexico medical device market through Pure Global AI's free database. This Clase II medical device is registered under COFEPRIS analysis ID 1247R2024 SSA and manufactured by ISA HEALTH, S.A. DE C.V.. The device was registered on April 30, 2024.

This page provides complete registration details including product type (III. Agentes de diagnóstico), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.

Free Database
Powered by Pure Global AI
COFEPRIS Official Data
Clase II
1247R2024 SSA
REACTIVO PARA DETERMINACIÓN CUANTITATIVA DE CA15-3 (ANTÍGENO CANCERÍGENO 15-3)
COFEPRIS Analysis ID: 1247R2024 SSA
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Device Classification
Risk Class / Clase de Riesgo
Clase II
Product Type (Spanish)
III. Agentes de diagnóstico
Product Type (English)
III. Agentes de diagnóstico
Trade Name (Spanish)
CA15-3 CLIA MICROPARTICLES AUTOBIO DIAGNOSTICS
Trade Name (English)
CA15-3 CLIA MICROPARTICLES AUTOBIO DIAGNOSTICS
Registration Information
Analysis ID
1247R2024 SSA
Registration Date
April 30, 2024
Manufacturer / Fabricante
Name (English)
ISA HEALTH, S.A. DE C.V.